Walsh Patrick D 4

What Happened
Patrick D. Walsh, a director of ANI Pharmaceuticals, reported an open-market sale of 6,000 shares on March 3, 2026. The shares were sold at $74.23 each for a total transaction value of approximately $445,380. This was a sale (not a purchase), which is commonly routine insider selling rather than a direct signal of company outlook.

Key Details

• Transaction date: 2026-03-03
• Transaction type/code: Open-market sale (S)
• Price per share: $74.23
• Shares sold: 6,000
• Total proceeds: ~$445,380
• Shares owned after transaction: Not specified in the provided filing
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other footnotes disclosed in the provided summary
• Filing timeliness: Reported on the same day (no late filing indicated)

Context
This was an ordinary-course sale by a company director through the open market. Sales by insiders can be for many personal reasons (diversification, liquidity, tax planning) and are not by themselves proof of management’s view on future company performance. Retail investors should consider this alongside other insider activity, company fundamentals, and market conditions.